FDA Approved Products

6,646 products with lifecycle intelligence, competitive pressure scores, and patent timelines.

Type:AllNDABLAANDA
Lifecycle:GrowthPeakLOE ApproachingPost-LOELaunchPre-Launch
Sort:Approval DateNameCompetitive Pressure↓
ACULAR
ketorolac tromethamine
LOE Approaching
AbbVie
OPHTHALMIC · SOLUTION/DROPS
postoperative inflammation in patients
1992
NDA
30/100
ACULAR PRESERVATIVE FREE
ketorolac tromethamine
LOE Approaching
AbbVie
OPHTHALMIC · SOLUTION/DROPS
1997
NDA
30/100
ACUTECT
technetium tc-99m apcitide
LOE Approaching
INJECTION · INJECTABLE
1998
PeptideNDA
30/100
ACZONE
dapsone
LOE Approaching
Almirall
TOPICAL · GEL
2005
NDA
30/100
ADALAT
nifedipine
LOE Approaching
R-Pharm US
ORAL · CAPSULE
hypertension
1985
SMNDA
30/100
ADALAT CC
nifedipine
LOE Approaching
ORAL · TABLET, EXTENDED RELEASE
hypertension
1993
SMNDA
30/100
ADCIRCA
tadalafil
LOE Approaching
Eli Lilly and Company
ORAL · TABLET
pulmonary arterial hypertension (PAH) (WHO Group 1) to improve exercise abilityhypertension
2009
NDA
30/100
ADDERALL 10
amphetamine aspartate; amphetamine sulfate; dextroamphetamine saccharate; dextroamphetamine sulfate
LOE Approaching
Teva
ORAL · TABLET
Attention Deficit Hyperactivity Disorder (ADHD) in patients 13 yearsolder+1
1960
NDA
30/100
ADDERALL 12.5
amphetamine aspartate; amphetamine sulfate; dextroamphetamine saccharate; dextroamphetamine sulfate
LOE Approaching
Teva
ORAL · TABLET
Attention Deficit Hyperactivity Disorder (ADHD) in patients 13 yearsolder+1
1960
NDA
30/100
ADDERALL 15
amphetamine aspartate; amphetamine sulfate; dextroamphetamine saccharate; dextroamphetamine sulfate
LOE Approaching
Teva
ORAL · TABLET
Attention Deficit Hyperactivity Disorder (ADHD) in patients 13 yearsolder+1
1960
NDA
30/100
ADDERALL 20
amphetamine aspartate; amphetamine sulfate; dextroamphetamine saccharate; dextroamphetamine sulfate
LOE Approaching
Teva
ORAL · TABLET
Attention Deficit Hyperactivity Disorder (ADHD) in patients 13 yearsolder+1
1960
NDA
30/100
ADDERALL 30
amphetamine aspartate; amphetamine sulfate; dextroamphetamine saccharate; dextroamphetamine sulfate
LOE Approaching
Teva
ORAL · TABLET
Attention Deficit Hyperactivity Disorder (ADHD) in patients 13 yearsolder+1
1960
NDA
30/100
ADDERALL 5
amphetamine aspartate; amphetamine sulfate; dextroamphetamine saccharate; dextroamphetamine sulfate
LOE Approaching
Teva
ORAL · TABLET
Attention Deficit Hyperactivity Disorder (ADHD) in patients 13 yearsolder+1
1960
NDA
30/100
ADDERALL 7.5
amphetamine aspartate; amphetamine sulfate; dextroamphetamine saccharate; dextroamphetamine sulfate
LOE Approaching
Teva
ORAL · TABLET
Attention Deficit Hyperactivity Disorder (ADHD) in patients 13 yearsolder+1
1960
NDA
30/100
ADDERALL XR 10
dextroamphetamine saccharate, amphetamine aspartate monohydrate, dextroamphetamine sulfate, and amphetamine sulfate
LOE Approaching
Takeda
ORAL · CAPSULE, EXTENDED RELEASE
attention deficit hyperactivity disorder (ADHD) in adultsolder
2001
NDA
30/100
ADDERALL XR 15
dextroamphetamine saccharate, amphetamine aspartate monohydrate, dextroamphetamine sulfate, and amphetamine sulfate
LOE Approaching
Takeda
ORAL · CAPSULE, EXTENDED RELEASE
attention deficit hyperactivity disorder (ADHD) in adultsolder
2001
NDA
30/100
ADDERALL XR 20
dextroamphetamine saccharate, amphetamine aspartate monohydrate, dextroamphetamine sulfate, and amphetamine sulfate
LOE Approaching
Takeda
ORAL · CAPSULE, EXTENDED RELEASE
attention deficit hyperactivity disorder (ADHD) in adultsolder
2001
NDA
30/100
ADDERALL XR 25
dextroamphetamine saccharate, amphetamine aspartate monohydrate, dextroamphetamine sulfate, and amphetamine sulfate
LOE Approaching
Takeda
ORAL · CAPSULE, EXTENDED RELEASE
attention deficit hyperactivity disorder (ADHD) in adultsolder
2001
NDA
30/100
ADDERALL XR 30
dextroamphetamine saccharate, amphetamine aspartate monohydrate, dextroamphetamine sulfate, and amphetamine sulfate
LOE Approaching
Takeda
ORAL · CAPSULE, EXTENDED RELEASE
attention deficit hyperactivity disorder (ADHD) in adultsolder
2001
NDA
30/100
ADDERALL XR 5
dextroamphetamine saccharate, amphetamine aspartate monohydrate, dextroamphetamine sulfate, and amphetamine sulfate
LOE Approaching
Takeda
ORAL · CAPSULE, EXTENDED RELEASE
attention deficit hyperactivity disorder (ADHD) in adultsolder
2001
NDA
30/100
ADENOCARD
adenosine
LOE Approaching
Astellas
INJECTION · INJECTABLE
atrial fibrillation
1989
NDA
30/100
ADENOSCAN
adenosine
LOE Approaching
Astellas
INTRAVENOUS · SOLUTION
atrial fibrillation
1995
NDA
30/100
ADRENACLICK
epinephrine
LOE Approaching
INTRAMUSCULAR, SUBCUTANEOUS · INJECTABLE
the emergency treatment of allergic reactions (Type I) including anaphylaxis
2003
NDA
30/100
ADREVIEW
iobenguane i-123
LOE Approaching
INTRAVENOUS · SOLUTION
heart failure
2008
NDA
30/100
← PreviousPage 5 of 277Next →